Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin

PURPOSE: Picoplatin is a new generation platinum designed to overcome platinum resistance. The goal of this study was to assess picoplatin anti-tumor activity and measure various cellular parameters in small-cell lung cancer (SCLC) cells resistant to cell killing by cisplatin and carboplatin. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Chi-Hui, Parham, Christi, Shocron, Ellyn, McMahon, Gerald, Patel, Neela
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102205/
https://www.ncbi.nlm.nih.gov/pubmed/20809122
http://dx.doi.org/10.1007/s00280-010-1435-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102205/
https://www.ncbi.nlm.nih.gov/pubmed/20809122
http://dx.doi.org/10.1007/s00280-010-1435-5

Ejemplares similares